Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Download CSV

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,280 authorised products are in this register. Synced 23 Oct 2026, 03:25 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Rowarolan Cutaneous Powder PA0074/046/001

Calcium carbonate

Rowa Pharmaceuticals Limited

Marketed

Rowatanal Cream PA0074/016/001

Bismuth subgallate, Zinc oxide, Menthol

Rowa Pharmaceuticals Limited

Marketed

Rowatinex Gastro-resistant Capsules, Soft PA0074/009/001

Beta pinene, Cineole, Camphene, Alpha pinene, Fenchone

Rowa Pharmaceuticals Limited,

Marketed

Rowatinex Oral Drops, Solution PA0074/009/002

Anethol, Alpha pinene, Borneol, Fenchone, Camphene

Rowa Pharmaceuticals Limited,

Not marketed

Rozex 7.5 mg/g Cream PA22743/013/002

Metronidazole

Galderma International

Not marketed

Rozex 7.5 mg/g Gel PA22743/013/001

Metronidazole

Galderma International

Not marketed

Rozlytrek 100 mg hard capsules EU/1/20/1460/001

Entrectinib

Roche Registration GmbH

—

Rozlytrek 200 mg hard capsules EU/1/20/1460/002

Entrectinib

Roche Registration GmbH

—

Rozlytrek 50 mg film-coated granules in sachet EU/1/20/1460/003

Entrectinib

Roche Registration GmbH

—

Rubraca 200 mg Film-coated tablet EU/1/17/1250/001

Rucaparib camsylate

pharmaand GmbH

—

Rubraca 250 mg Film-coated tablet EU/1/17/1250/002

Rucaparib camsylate

pharmaand GmbH

—

Rubraca 300 mg Film-coated tablet EU/1/17/1250/003

Rucaparib camsylate

pharmaand GmbH

—

Ruconest 2100 Units powder and solvent for solution for injection EU/1/10/641/002

Conestat alfa

Pharming Group N.V.

—

Ruconest 2100 Units powder for solution for injection EU/1/10/641/001

Conestat alfa

Pharming Group N.V.

—

Rukobia 600 mg prolonged-release tablets EU/1/20/1518/001

Fostemsavir Tromethamine

ViiV Healthcare BV

—

Rupafin 1 mg/ml oral solution PA1129/001/002

Rupatadine

J. Uriach y Compania S.A.

Not marketed

Rupafin 10mg tablets PA1129/001/001

Rupatadine fumarate

J. Uriach y Compania S.A.

Marketed

Ruta grav HOR1149/026/001

Ruta graveolens

A. Nelson & Company Limited

Not marketed

Ruxience 100 mg concentrate for solution for infusion EU/1/20/1431/001

Rituximab

Pfizer Europe MA EEIG

—

Ruxience 500 mg concentrate for solution for infusion EU/1/20/1431/002

Rituximab

Pfizer Europe MA EEIG

—

RXULTI 0.25 mg Film-coated tablet EU/1/18/1294/001

Brexpiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

RXULTI 0.5 mg Film-coated tablet EU/1/18/1294/002

Brexpiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

RXULTI 1 mg Film-coated tablet EU/1/18/1294/003-004

Brexpiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

RXULTI 2 mg Film-coated tablet EU/1/18/1294/005

Brexpiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

RXULTI 3 mg Film-coated tablet EU/1/18/1294/006

Brexpiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

RXULTI 4 mg Film-coated tablet EU/1/18/1294/007

Brexpiprazole

Otsuka Pharmaceutical Netherlands B.V.

—

Ryaltris 25 microgram/actuation + 600 microgram/actuation nasal spray, suspension PA1543/002/001

Mometasone furoate, Olopatadine

Glenmark Pharmaceuticals s.r.o.

Marketed

Ryaltris 25 microgram/actuation + 600 microgram/actuation nasal spray, suspension PPA0465/507/001

Mometasone furoate, Olopatadine

PCO Manufacturing Ltd.

—

Rybelsus 1.5 mg tablets EU/1/20/1430/016-020

Semaglutide

Novo Nordisk A/S

—

Rybelsus 14 mg tablets EU/1/20/1430/008-010

Semaglutide

Novo Nordisk A/S

—

Rybelsus 25 mg tablets EU/1/20/1430/031-035

Semaglutide

Novo Nordisk A/S

—

Rybelsus 3 mg tablets EU/1/20/1430/001-004

Semaglutide

Novo Nordisk A/S

—

Rybelsus 4 mg tablets EU/1/20/1430/021-025

Semaglutide

Novo Nordisk A/S

—

Rybelsus 50 mg tablets EU/1/20/1430/036-040

Semaglutide

Novo Nordisk A/S

—

Rybelsus 7 mg tablets EU/1/20/1430/005-007

Semaglutide

Novo Nordisk A/S

—

Rybelsus 9 mg tablets EU/1/20/1430/026-030

Semaglutide

Novo Nordisk A/S

—

Rybrevant 1 600 mg solution for injection EU/1/21/1594/002

Amivantamab

Janssen-Cilag International NV

—

Rybrevant 2240 mg solution for injection EU/1/21/1594/003

Amivantamab

Janssen-Cilag International NV

—

Rybrevant 350 mg concentrate for solution for infusion EU/1/21/1594/001

Amivantamab

Janssen-Cilag International NV

—

Rydapt 25 mg soft capsules EU/1/17/1218/001

Midostaurin

Novartis Europharm Limited

—

Ryeqo 40 mg/1 mg/0.5 mg film-coated tablets EU/1/21/1565/001-002

Relugolix, Estradiol hemihydrate, Norethisterone acetate

Gedeon Richter Plc

—

Ryjunea 0.1 mg/ml eye drops, solution EU/1/25/1920/001-002

Atropine sulfate

Santen OY

—

Rystiggo 140 mg/ml solution for injection EU/1/23/1780/001

Rozanolixizumab

UCB Pharma S.A.

—

Rytelo 188 mg powder for concentrate for solution for infusion EU/1/24/1894/002

Imetelstat sodium

Geron Netherlands B.V.

—

Rytelo 47 mg powder for concentrate for solution for infusion EU/1/24/1894/001

Imetelstat sodium

Geron Netherlands B.V.

—

Ryzneuta 20 mg solution for injection EU/1/24/1793/001

Efbemalenograstim alfa

Fisiopharma SrL

—

Ryzodeg 100 units/mL solution for injection EU/1/12/806/1,4,5,7,8

Insulin degludec (ideg), Insulin aspart

Novo Nordisk A/S

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 23 October 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.